vs
Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $182.4M, roughly 1.8× Climb Global Solutions, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 1.8%, a 2.2% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs 2.2%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
CLMB vs GRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $182.4M | $336.6M |
| Net Profit | $3.3M | $13.5M |
| Gross Margin | 14.5% | 22.7% |
| Operating Margin | 2.1% | 5.3% |
| Net Margin | 1.8% | 4.0% |
| Revenue YoY | 32.1% | 2.2% |
| Net Profit YoY | -9.5% | 46.1% |
| EPS (diluted) | $0.18 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $182.4M | $336.6M | ||
| Q4 25 | $193.8M | $397.6M | ||
| Q3 25 | $161.3M | $377.4M | ||
| Q2 25 | $159.3M | $344.3M | ||
| Q1 25 | $138.0M | $329.3M | ||
| Q4 24 | $161.8M | — | ||
| Q3 24 | $119.3M | $314.4M | ||
| Q2 24 | $92.1M | — |
| Q1 26 | $3.3M | $13.5M | ||
| Q4 25 | $7.0M | $20.9M | ||
| Q3 25 | $4.7M | $9.8M | ||
| Q2 25 | $6.0M | $9.0M | ||
| Q1 25 | $3.7M | $9.4M | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $5.5M | $-122.0M | ||
| Q2 24 | $3.4M | — |
| Q1 26 | 14.5% | 22.7% | ||
| Q4 25 | 15.4% | 21.5% | ||
| Q3 25 | 15.9% | 19.8% | ||
| Q2 25 | 16.5% | 19.8% | ||
| Q1 25 | 16.9% | 19.5% | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 20.3% | 19.4% | ||
| Q2 24 | 20.2% | — |
| Q1 26 | 2.1% | 5.3% | ||
| Q4 25 | 4.9% | 7.7% | ||
| Q3 25 | 4.3% | 4.3% | ||
| Q2 25 | 5.0% | 3.7% | ||
| Q1 25 | 3.5% | 3.9% | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 7.1% | -33.3% | ||
| Q2 24 | 4.6% | — |
| Q1 26 | 1.8% | 4.0% | ||
| Q4 25 | 3.6% | 5.3% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 3.7% | 2.6% | ||
| Q1 25 | 2.7% | 2.9% | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 4.6% | -38.8% | ||
| Q2 24 | 3.7% | — |
| Q1 26 | $0.18 | $0.21 | ||
| Q4 25 | $1.51 | — | ||
| Q3 25 | $1.02 | — | ||
| Q2 25 | $1.30 | — | ||
| Q1 25 | $0.81 | — | ||
| Q4 24 | $1.52 | — | ||
| Q3 24 | $1.19 | — | ||
| Q2 24 | $0.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.8M | $64.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $118.4M | $232.4M |
| Total Assets | $458.8M | $426.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.8M | $64.9M | ||
| Q4 25 | $36.6M | $65.6M | ||
| Q3 25 | $49.8M | $36.5M | ||
| Q2 25 | $28.6M | $18.8M | ||
| Q1 25 | $32.5M | $14.0M | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $22.1M | $37.2M | ||
| Q2 24 | $48.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | — |
| Q1 26 | $118.4M | $232.4M | ||
| Q4 25 | $116.6M | $217.9M | ||
| Q3 25 | $109.3M | $195.5M | ||
| Q2 25 | $105.2M | $179.7M | ||
| Q1 25 | $95.6M | $163.2M | ||
| Q4 24 | $90.6M | — | ||
| Q3 24 | $87.7M | $133.9M | ||
| Q2 24 | $79.8M | — |
| Q1 26 | $458.8M | $426.9M | ||
| Q4 25 | $460.2M | $412.7M | ||
| Q3 25 | $376.1M | $390.0M | ||
| Q2 25 | $420.7M | $356.3M | ||
| Q1 25 | $370.1M | $334.0M | ||
| Q4 24 | $469.2M | — | ||
| Q3 24 | $371.9M | $348.0M | ||
| Q2 24 | $302.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $6.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | $-11.9M | $34.6M | ||
| Q3 25 | $22.2M | $28.2M | ||
| Q2 25 | $-2.2M | $19.9M | ||
| Q1 25 | $8.5M | $17.6M | ||
| Q4 24 | $16.0M | — | ||
| Q3 24 | $-3.6M | — | ||
| Q2 24 | $7.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | -1.70× | 1.65× | ||
| Q3 25 | 4.73× | 2.87× | ||
| Q2 25 | -0.37× | 2.21× | ||
| Q1 25 | 2.30× | 1.86× | ||
| Q4 24 | 2.29× | — | ||
| Q3 24 | -0.66× | — | ||
| Q2 24 | 2.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
